NPC1L1 | NPC1-like 1 | FDA approved drug targets Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
OTOP3 | Otopetrin 3 | Predicted membrane proteins
| ![](/images/23498/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/23498/50579_B_9_2_rna_selected_60x60.jpg) | Tissue enriched |
PCK2 | Phosphoenolpyruvate carboxykinase 2 (mitochondrial) | Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | ![](/images/51162/ihc_cell_selected_60x60.jpg) | ![](/images/51162/124857_B_8_2_rna_selected_60x60.jpg) | Group enriched |
PDX1 | Pancreatic and duodenal homeobox 1 | Disease related genes Transcription factors
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/25873/54798_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
SLC15A1 | Solute carrier family 15 (oligopeptide transporter), member 1 | Predicted membrane proteins Transporters
| ![](/images/2827/ihc_selected_60x60.jpg) | ![](/images/2827/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/2827/8322_B_8_8_rna_selected_60x60.jpg) | Group enriched |
SLC23A3 | Solute carrier family 23, member 3 | Predicted membrane proteins Predicted secreted proteins Transporters
| ![](/images/19059/ihc_selected_60x60.jpg) | ![](/images/19059/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/19059/44568_B_8_6_rna_selected_60x60.jpg) | Group enriched |
SLC26A3 | Solute carrier family 26 (anion exchanger), member 3 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/36055/70818_B_1_8_rna_selected_60x60.jpg) | Group enriched |
SLC9A3 | Solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 | Predicted membrane proteins Transporters
| | | ![](/images_static/rna_center.gif) | ![](/images/36493/78436_B_9_2_rna_selected_60x60.jpg) | Group enriched |
SMLR1 | Small leucine-rich protein 1 | Predicted membrane proteins
| ![](/images/66060/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/66060/146006_B_2_5_rna_selected_60x60.jpg) | Group enriched |
SPINK4 | Serine peptidase inhibitor, Kazal type 4 | Predicted secreted proteins
| | ![](/images/7286/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/7286/23641_B_8_2_rna_selected_60x60.jpg) | Group enriched |
SULT1B1 | Sulfotransferase family, cytosolic, 1B, member 1 | Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/2107/142116_B_9_3_rna_selected_60x60.jpg) | Group enriched |
TMEM132E | Transmembrane protein 132E | Disease related genes Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
TMEM253 | Transmembrane protein 253 | Predicted membrane proteins
| | ![](/images/52329/if_selected_60x60.jpg) | ![](/images/52329/ihc_cell_selected_60x60.jpg) | ![](/images/52329/116988_B_8_5_rna_selected_60x60.jpg) | Group enriched |
TRPM6 | Transient receptor potential cation channel, subfamily M, member 6 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/7037/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/7037/19333_B_9_1_rna_selected_60x60.jpg) | Group enriched |
UGT2B17 | UDP glucuronosyltransferase 2 family, polypeptide B17 | Enzymes Predicted membrane proteins
| ![](/images/45108/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45108/105018_B_9_1_rna_selected_60x60.jpg) | Group enriched |
VNN1 | Vanin 1 | Enzymes Plasma proteins Predicted secreted proteins
| ![](/images/64145/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/64145/150365_A_1_4_rna_selected_60x60.jpg) | Group enriched |
ACY1 | Aminoacylase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | ![](/images/36175/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/36174/98822_B_8_3_rna_selected_60x60.jpg) | Group enriched |
AMN | Amnion associated transmembrane protein | Disease related genes Predicted membrane proteins
| ![](/images/817/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/817/1309_B_7_5_rna_selected_60x60.jpg) | Group enriched |
ANPEP | Alanyl (membrane) aminopeptidase | CD markers Enzymes Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/2417/6119_B_9_2_rna_selected_60x60.jpg) | Group enriched |
BCL2L15 | BCL2-like 15 | | ![](/images/29733/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/29733/63011_B_5_6_rna_selected_60x60.jpg) | Group enriched |
CAPN13 | Calpain 13 | Enzymes
| ![](/images/29497/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/29497/72321_B_9_1_rna_selected_60x60.jpg) | Group enriched |
CDX2 | Caudal type homeobox 2 | Cancer-related genes Transcription factors
| | | | ![](/images/2221/5839_B_9_3_rna_selected_60x60.jpg) | Group enriched |
DEPDC7 | DEP domain containing 7 | | ![](/images/15800/ihc_selected_60x60.jpg) | ![](/images/15800/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/15800/35841_B_7_8_rna_selected_60x60.jpg) | Group enriched |
DHDH | Dihydrodiol dehydrogenase (dimeric) | Enzymes
| | ![](/images/44131/if_selected_60x60.jpg) | ![](/images/44131/ihc_cell_selected_60x60.jpg) | ![](/images/44131/97426_B_2_6_rna_selected_60x60.jpg) | Group enriched |
ENPEP | Glutamyl aminopeptidase (aminopeptidase A) | CD markers Enzymes Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/5128/14084_A_7_2_rna_selected_60x60.jpg) | Group enriched |
HTR1D | 5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| ![](/images/22775/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/22770/90919_B_8_1_rna_selected_60x60.jpg) | Group enriched |
ITLN2 | Intelectin 2 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/6683/ihc_cell_selected_60x60.jpg) | ![](/images/6683/20105_B_9_2_rna_selected_60x60.jpg) | Group enriched |
KCNJ3 | Potassium inwardly-rectifying channel, subfamily J, member 3 | Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/24231/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/24231/52330_B_7_4_rna_selected_60x60.jpg) | Group enriched |
MGAM | Maltase-glucoamylase (alpha-glucosidase) | Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/2270/8419_B_8_5_rna_selected_60x60.jpg) | Group enriched |
MUC17 | Mucin 17, cell surface associated | Cancer-related genes Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/31634/72330_B_8_2_rna_selected_60x60.jpg) | Group enriched |
PIGR | Polymeric immunoglobulin receptor | Cancer-related genes Plasma proteins Predicted membrane proteins
| | ![](/images/12012/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/12012/28147_B_9_8_rna_selected_60x60.jpg) | Group enriched |
PLCB3 | Phospholipase C, beta 3 (phosphatidylinositol-specific) | Enzymes
| | | | ![](/images/9257/141347_B_8_4_rna_selected_60x60.jpg) | Group enriched |
PPP1R14D | Protein phosphatase 1, regulatory (inhibitor) subunit 14D | | ![](/images/41846/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/41846/88528_A_4_3_rna_selected_60x60.jpg) | Group enriched |
REG4 | Regenerating islet-derived family, member 4 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/25867/57482_B_2_4_rna_selected_60x60.jpg) | Group enriched |
RP11-595B24.2 | Uncharacterized protein | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
SHD | Src homology 2 domain containing transforming protein D | | ![](/images/17955/ihc_selected_60x60.jpg) | ![](/images/17955/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/17955/40889_B_7_7_rna_selected_60x60.jpg) | Group enriched |
SST | Somatostatin | Cancer-related genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/19472/ihc_cell_selected_60x60.jpg) | ![](/images/75/201_B_2_1_rna_selected_60x60.jpg) | Group enriched |
SULT1A2 | Sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2 | Enzymes
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/51051/113946_B_8_4_rna_selected_60x60.jpg) | Group enriched |
TMEM92 | Transmembrane protein 92 | Predicted membrane proteins
| ![](/images/63009/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/63009/143465_B_1_8_rna_selected_60x60.jpg) | Group enriched |
UNC93A | Unc-93 homolog A (C. elegans) | Predicted membrane proteins
| ![](/images/35729/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/35729/83581_B_8_4_rna_selected_60x60.jpg) | Group enriched |
USH1C | Usher syndrome 1C (autosomal recessive, severe) | Cancer-related genes Cytoskeleton related proteins Disease related genes
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13690/31410_B_8_6_rna_selected_60x60.jpg) | Group enriched |
XDH | Xanthine dehydrogenase | Disease related genes Enzymes FDA approved drug targets Plasma proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
AADAC | Arylacetamide deacetylase | Enzymes
| ![](/images/2911/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/2911/10291_B_8_8_rna_selected_60x60.jpg) | Tissue enhanced |
AC012215.1 | Uncharacterized protein | Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
AC021218.2 | Uncharacterized protein | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
ACE2 | Angiotensin I converting enzyme 2 | Enzymes FDA approved drug targets Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/26174/58083_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
ACY3 | Aspartoacylase (aminocyclase) 3 | Enzymes
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/39219/83702_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
AKR1B10 | Aldo-keto reductase family 1, member B10 (aldose reductase) | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/20280/153432_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
AKR1B15 | Aldo-keto reductase family 1, member B15 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/20280/153432_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
AKR7A3 | Aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |